| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Ralf Weiskirchen | Q51753160 |
| P2093 | author name string | Axel M Gressner | |
| Jens Herrmann | |||
| P2860 | cites work | Effect of six flavonoids on proliferation of hepatic stellate cells in vitro | Q73810103 |
| Proteome analysis of rat hepatic stellate cells | Q74071343 | ||
| Transforming growth factor beta signal transduction in hepatic stellate cells via Smad2/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts. TGFbeta signal transduction during transdifferentiation of hepatic | Q74292004 | ||
| CD133+ hepatic stellate cells are progenitor cells | Q79373868 | ||
| [Inhibitory effect of interferon-beta on the activation of LX-2 and rHSC-99 hepatic stellate cells in culture] | Q79985217 | ||
| Leptin enhances alpha1(I) collagen gene expression in LX-2 human hepatic stellate cells through JAK-mediated H2O2-dependent MAPK pathways | Q81237663 | ||
| Isolated hepatic lipocytes and kupffer cells from normal human liver: Morphological and functional characteristics in primary culture | Q67743331 | ||
| Liver fat storing cell proliferation is stimulated by epidermal growth factor/transforming growth factor alpha and inhibited by transforming growth factor beta | Q69742276 | ||
| Purified Rat Liver Fat-Storing Cells in Culture Divide and Contain Collagen | Q70354518 | ||
| Three-dimensional structure of extracellular matrix reversibly regulates morphology, proliferation and collagen metabolism of perisinusoidal stellate cells (vitamin A-storing cells) | Q71807359 | ||
| Human myofibroblastlike cells obtained by outgrowth are representative of the fibrogenic cells in the liver | Q72016105 | ||
| Heterogeneity of liver cells expressing procollagen types I and IV in vivo | Q73478657 | ||
| Modulation of transforming growth factor beta response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts | Q73746119 | ||
| Comparative evaluation of gene delivery devices in primary cultures of rat hepatic stellate cells and rat myofibroblasts | Q24795349 | ||
| History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells | Q28190388 | ||
| Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets | Q28303698 | ||
| PDGF-BB induces expression of LTBP-1 but not TGF-beta1 in a rat cirrhotic fat storing cell line | Q28577034 | ||
| Transforming growth factor beta1 induces the expression of alpha1(I) procollagen mRNA by a hydrogen peroxide-C/EBPbeta-dependent mechanism in rat hepatic stellate cells | Q28582231 | ||
| Pro-fibrogenic potential of PDGF-D in liver fibrosis | Q28583234 | ||
| Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice | Q31045022 | ||
| Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury | Q33822590 | ||
| Cooperation of liver cells in health and disease | Q34103771 | ||
| Roles of TGF-beta in hepatic fibrosis | Q34565570 | ||
| Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells | Q34580695 | ||
| Immortal activated human hepatic stellate cells generated by ectopic telomerase expression | Q38291132 | ||
| Hepatocyte growth factor induces collagenase (matrix metalloproteinase-1) via the transcription factor Ets-1 in human hepatic stellate cell line | Q38292286 | ||
| An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro. | Q38311930 | ||
| Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. | Q38333252 | ||
| Replicative senescence of activated human hepatic stellate cells is accompanied by a pronounced inflammatory but less fibrogenic phenotype | Q38357362 | ||
| Leptin enhances the effect of transforming growth factor beta in increasing type I collagen formation | Q38362368 | ||
| Expression and upregulation of cathepsin S and other early molecules required for antigen presentation in activated hepatic stellate cells upon IFN-gamma treatment | Q40193409 | ||
| Inhibitory effect of emodin on tissue inhibitor of metalloproteinases-1 (TIMP-1) expression in rat hepatic stellate cells | Q40198021 | ||
| Effects of rhDecorin on TGF-beta1 induced human hepatic stellate cells LX-2 activation | Q40215136 | ||
| Leptin represses matrix metalloproteinase-1 gene expression in LX2 human hepatic stellate cells | Q40222219 | ||
| PPARgamma agonists prevent TGFbeta1/Smad3-signaling in human hepatic stellate cells | Q40225700 | ||
| The expression of CSRP2 encoding the LIM domain protein CRP2 is mediated by TGF-beta in smooth muscle and hepatic stellate cells | Q40273781 | ||
| Interleukin-1 beta up-regulates tissue inhibitor of matrix metalloproteinase-1 mRNA and phosphorylation of c-jun N-terminal kinase and p38 in hepatic stellate cells | Q40301210 | ||
| A new immortalized rat cell line, hepatic stellate cell-PQ, exhibiting characteristics of hepatic stellate cell. | Q40419126 | ||
| Angiotensin II participates in hepatic inflammation and fibrosis through MCP-1 expression | Q40419536 | ||
| The plasticity of p19 ARF null hepatic stellate cells and the dynamics of activation. | Q40425998 | ||
| Effect of IL-4 and IL-13 on collagen production in cultured LI90 human hepatic stellate cells | Q40444779 | ||
| Effect of prostaglandin E2 and prostaglandin I2 on PDGF-induced proliferation of LI90, a human hepatic stellate cell line | Q40513357 | ||
| Tumor necrosis factor-alpha inhibits peroxisome proliferator-activated receptor gamma activity at a posttranslational level in hepatic stellate cells | Q40610380 | ||
| Leptin stimulates tissue inhibitor of metalloproteinase-1 in human hepatic stellate cells: respective roles of the JAK/STAT and JAK-mediated H2O2-dependant MAPK pathways | Q40615430 | ||
| Reverse transformation of hepatic myofibroblast-like cells by TGFbeta1/LAP. | Q40615930 | ||
| Triiodothyronine and interleukin-6 (IL-6) induce expression of HGF in an immortalized rat hepatic stellate cell line | Q40637668 | ||
| Establishment of an immortalized human hepatic stellate cell line to develop antifibrotic therapies | Q40638123 | ||
| Treatment of the rat hepatic stellate cell line, PAV-1, by retinol and palmitic acid leads to a convenient model to study retinoids metabolism. | Q40681219 | ||
| PAV-1, a new rat hepatic stellate cell line converts retinol into retinoic acid, a process altered by ethanol. | Q40732567 | ||
| Differential regulation of TGF-beta signal in hepatic stellate cells between acute and chronic rat liver injury | Q40757687 | ||
| Induction of the lipocyte phenotype in murine hepatic stellate cells: reorganisation of the actin cytoskeleton. | Q40772003 | ||
| Intermediate filaments modulation in an in vitro model of the hepatic stellate cell activation or conversion into the lipocyte phenotype | Q40783124 | ||
| Reversal of activation of human myofibroblast-like cells by culture on a basement membrane-like substrate | Q60537805 | ||
| Inhibitory effects of antisense oligonucleotides on the expression of procollagen type III gene in mouse hepatic stellate cells transformed by simian virus 40. | Q40836363 | ||
| Tumor necrosis factor alpha down-regulates expression of the alpha1(I) collagen gene in rat hepatic stellate cells through a p20C/EBPbeta- and C/EBPdelta-dependent mechanism. | Q40882326 | ||
| Inhibition of hyaluronan synthesis by vesnarinone in cultured human myofibroblasts | Q40902542 | ||
| Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential | Q40921225 | ||
| Induction of calponin-h1 by transforming growth factor-beta1 in cultured human ito cells, LI90. | Q41035301 | ||
| Cell growth and differentiation of a novel mouse Ito (fat-storing) cell line transformed by a temperature-sensitive mutant of simian virus 40. | Q41097749 | ||
| Characterization of a new human liver myofibroblast cell line: transcriptional regulation of plasminogen activator inhibitor type I by transforming growth factor beta 1. | Q41101457 | ||
| Effects of retinol on proliferation, cell adherence and extracellular matrix synthesis in a liver myofibroblast or lipocyte cell line (GRX). | Q41155909 | ||
| Establishment of a new human cell line, LI90, exhibiting characteristics of hepatic Ito (fat-storing) cells. | Q41342641 | ||
| Characterization of fat-storing cell lines derived from normal and CCl4-cirrhotic livers. Differences in the production of interleukin-6 | Q41654901 | ||
| Interferon alfa down-regulates collagen gene transcription and suppresses experimental hepatic fibrosis in mice | Q42450667 | ||
| Regulation of the α2(I) collagen gene transcription in fat-storing cells derived from a cirrhotic liver | Q42804307 | ||
| Urokinase plasminogen activator stimulates function of active forms of stromelysin and gelatinases (MMP-2 and MMP-9) in cirrhotic tissue | Q42805229 | ||
| Liver fat-storing cell clones obtained from a CCl4-cirrhotic rat are heterogeneous with regard to proliferation, expression of extracellular matrix components, interleukin-6, and connexin 43. | Q42809891 | ||
| Induction of apoptosis by tanshinone I via cytochrome c release in activated hepatic stellate cells. | Q44445221 | ||
| Establishment of immortalized human hepatic stellate scavenger cells to develop bioartificial livers. | Q44481012 | ||
| Aldosterone stimulating PDGF-B expression in HSC via activation of EGR-1 | Q46644086 | ||
| Isolation and culture of hepatic stellate cells | Q46666110 | ||
| Angiotensin II and aldosterone stimulate alpha1-(I) procollagen mRNA expression in hepatic stellate cells via activation of ERK1/2 and AP-1 | Q46777233 | ||
| Immunosuppressant FK506 inhibits matrix metalloproteinase-9 induction in TNF-alpha-stimulated human hepatic stellate cells | Q46816197 | ||
| Smad3 specific inhibitor, naringenin, decreases the expression of extracellular matrix induced by TGF-beta1 in cultured rat hepatic stellate cells | Q46845532 | ||
| Zonal and regional differences identified from precision mapping of vitamin A-storing lipid droplets of the hepatic stellate cells in pig liver: a novel concept of addressing the intralobular area of heterogeneity | Q48599442 | ||
| Purification of rat hepatic stellate cells by side scatter-activated cell sorting. | Q50525615 | ||
| A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations. | Q50785680 | ||
| Establishment of a continuous cell line from fibrotic schistosomal granulomas in mice livers. | Q52830872 | ||
| Effect of ribozyme against transforming growth factorbeta1 on biological character of activated HSCs. | Q53665264 | ||
| [Effects of gamma-interferon on gene expression of collagen I, III and on the tissue inhibitor of metalloprotenase 1 in HSC-T6 cells]. | Q53959492 | ||
| P4510 | describes a project that uses | HSC 180 | Q54896369 |
| HSC-PQ | Q54896417 | ||
| HSC-T6 | Q54896418 | ||
| hTERT-HSC | Q54896630 | ||
| LX-1 | Q54903296 | ||
| LX-2 | Q54903298 | ||
| M1-4HSC | Q54903439 | ||
| MFBY2 | Q54905374 | ||
| NFSC | Q54930451 | ||
| PAV-1 | Q54938333 | ||
| SV68c-IS | Q54970980 | ||
| T-HSC/Cl-6 | Q54971363 | ||
| A640-IS | Q54607176 | ||
| A7 | Q54607181 | ||
| BSC | Q54798389 | ||
| BSC-C10 | Q54798390 | ||
| CFSC | Q54811453 | ||
| GREF-X | Q54871686 | ||
| GRX | Q54871708 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell line | Q21014462 |
| hepatocyte | Q827450 | ||
| cell biology | Q7141 | ||
| cell | Q7868 | ||
| biomedical investigative technique | Q66648976 | ||
| P304 | page(s) | 704-722 | |
| P577 | publication date | 2007-07-01 | |
| P1433 | published in | Journal of Cellular and Molecular Medicine | Q1524063 |
| P1476 | title | Immortal hepatic stellate cell lines: useful tools to study hepatic stellate cell biology and function? | |
| P478 | volume | 11 |
| Q54607176 | A640-IS |
| Q54607181 | A7 |
| Q54798389 | BSC |
| Q54798390 | BSC-C10 |
| Q54811453 | CFSC |
| Q54811454 | CFSC-2G |
| Q54811455 | CFSC-3H |
| Q54811456 | CFSC-5H |
| Q54811457 | CFSC-8B |
| Q54871686 | GREF-X |
| Q54871708 | GRX |
| Q54896369 | HSC 180 |
| Q54896417 | HSC-PQ |
| Q54896418 | HSC-T6 |
| Q54903296 | LX-1 |
| Q54903298 | LX-2 |
| Q54903439 | M1-4HSC |
| Q54905374 | MFBY2 |
| Q54930451 | NFSC |
| Q54938333 | PAV-1 |
| Q54970980 | SV68c-IS |
| Q54971363 | T-HSC/Cl-6 |
| Q54896630 | hTERT-HSC |
| Q39251464 | A Pathway to Personalizing Therapy for Metastases Using Liver-on-a-Chip Platforms. |
| Q44809819 | Activated hepatic stellate cells mediate the differentiation of macrophages |
| Q45953671 | Alteration of the ERK5 pathway by hydroxysafflor yellow A blocks expression of MEF2C in activated hepatic stellate cells in vitro: Potential treatment for hepatic fibrogenesis. |
| Q39676905 | Co-culture based blood-brain barrier in vitro model, a tissue engineering approach using immortalized cell lines for drug transport study |
| Q38718726 | Co-targeting HGF/cMET Signaling with MEK Inhibitors in Metastatic Uveal Melanoma |
| Q82234749 | Elevated free fatty acids and impaired adiponectin bioactivity contribute to reduced SOD2 protein in monocytes of type 2 diabetes patients |
| Q82299271 | Epimorphin promotes human hepatocellular carcinoma invasion and metastasis through activation of focal adhesion kinase/extracellular signal-regulated kinase/matrix metalloproteinase-9 axis |
| Q37363773 | Experimental liver fibrosis research: update on animal models, legal issues and translational aspects |
| Q36442525 | Experimental models of liver fibrosis |
| Q38699438 | Fructose-1,6-bisphosphate reverts iron-induced phenotype of hepatic stellate cells by chelating ferrous ions. |
| Q33608724 | F‑actin cytoskeleton reorganization is associated with hepatic stellate cell activation |
| Q35014533 | Genetic characteristics of the human hepatic stellate cell line LX-2. |
| Q36065064 | HIV and HCV Co-Culture Promotes Profibrogenic Gene Expression through an Epimorphin-Mediated ERK Signaling Pathway in Hepatic Stellate Cells |
| Q54968056 | Hepatic stellate cells secrete Ccl5 to induce hepatocyte steatosis. |
| Q45366886 | Hepatitis C virus core protein induces fibrogenic actions of hepatic stellate cells via toll-like receptor 2. |
| Q34372661 | Hepatocyte apoptotic bodies encasing nonstructural HCV proteins amplify hepatic stellate cell activation: implications for chronic hepatitis C. |
| Q42322952 | Human antigen R contributes to hepatic stellate cell activation and liver fibrosis |
| Q45931088 | Human hepatic stellate cell isolation and characterization. |
| Q39471795 | Human hepatic stellate cell line (LX-2) exhibits characteristics of bone marrow-derived mesenchymal stem cells. |
| Q38816350 | Inhibition of IRF3 expression reduces TGF-β1-induced proliferation of hepatic stellate cells |
| Q45871148 | Isolation and Culture of Primary Murine Hepatic Stellate Cells |
| Q36202215 | Karyotype alteration generates the neoplastic phenotypes of SV40-infected human and rodent cells |
| Q39837032 | Lycopene isomerisation and storage in an in vitro model of murine hepatic stellate cells |
| Q37134618 | Niemann-Pick Type C2 Protein Mediates Hepatic Stellate Cells Activation by Regulating Free Cholesterol Accumulation |
| Q34598380 | Overexpression of endoglin modulates TGF-β1-signalling pathways in a novel immortalized mouse hepatic stellate cell line |
| Q50876050 | Platelet-Derived Growth Factor Receptor α Contributes to Human Hepatic Stellate Cell Proliferation and Migration. |
| Q28728604 | Proteomic analysis of extracellular matrix from the hepatic stellate cell line LX-2 identifies CYR61 and Wnt-5a as novel constituents of fibrotic liver |
| Q91689967 | SCARNA10, a nuclear-retained long non-coding RNA, promotes liver fibrosis and serves as a potential biomarker |
| Q34979996 | SPARC downregulation attenuates the profibrogenic response of hepatic stellate cells induced by TGF-β1 and PDGF |
| Q37705049 | Secreted phospholipase A2 of Clonorchis sinensis activates hepatic stellate cells through a pathway involving JNK signalling |
| Q64298451 | Therapeutic effect of DC. extracts on activated hepatic stellate cells |
| Q37234131 | Transforming growth factor-β (TGF-β)-mediated connective tissue growth factor (CTGF) expression in hepatic stellate cells requires Stat3 signaling activation |
| Q33443530 | Up-regulation of uPARAP/Endo180 during culture activation of rat hepatic stellate cells and its presence in hepatic stellate cell lines from different species |
| Q64230111 | and its monomers alleviate liver fibrosis both in mice and LX2 cells by blocking TβR1-Smad2/3 and TNF-α-NF-κB pathways |
| Q37111117 | ω-3 PUFAs ameliorate liver fibrosis and inhibit hepatic stellate cells proliferation and activation by promoting YAP/TAZ degradation. |
Search more.